Cargando…

Lysosome-related genes: A new prognostic marker for lung adenocarcinoma

Currently, a reliable early prognostic marker has not been identified for lung adenocarcinoma (LUAD), the most common malignancy. Recent studies demonstrated that lysosomal rupture is involved in cancer migration, progression, and immune microenvironment formation. We performed a bioinformatics anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Zeyang, Chen, Hang, Li, Hongxiang, Xu, Shuguang, Mu, Yinyu, Pan, Qiaoling, Tong, Jingtao, Xu, Guodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476855/ https://www.ncbi.nlm.nih.gov/pubmed/37657029 http://dx.doi.org/10.1097/MD.0000000000034844

Ejemplares similares

IKZF3 is a novel prognostic biomarker for head and neck squamous cell carcinoma: A study based on bioinformatics analysis
por: Li, Hongxiang, et al.
Publicado: (2023)

Circular RNA expression profile in peripheral whole blood of lung adenocarcinoma by high: Throughput sequencing
por: Mu, Yinyu, et al.
Publicado: (2019)

In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma
por: Hu, Ankang, et al.
Publicado: (2023)

C-terminal binding protein-2 is a prognostic marker for lung adenocarcinomas
por: Li, Binfeng, et al.
Publicado: (2020)

Identification of an Autophagy-Related lncRNA Prognostic Signature and Related Tumor Immunity Research in Lung Adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2021)

Identification of TLRs as potential prognostic biomarkers for lung adenocarcinoma
por: Ying, Junjie, et al.
Publicado: (2023)

Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma
por: Liu, Zhi-Yan, et al.
Publicado: (2016)

Construction of an algorithm based on oncosis‐related LncRNAs comprising the molecular subtypes and a risk assessment model in lung adenocarcinoma
por: Chen, Hang, et al.
Publicado: (2022)

Mining prognostic factors of extensive-stage small-cell lung cancer patients using nomogram model
por: Gao, Hongxiang, et al.
Publicado: (2020)

Subcellular localization of β-arrestin1 and its prognostic value in lung adenocarcinoma
por: Li, Xiaowei, et al.
Publicado: (2017)

The prognostic effect of metastasis patterns on overall survival in organ metastatic lung adenocarcinoma
por: Tie, Xiaowei, et al.
Publicado: (2022)

A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review
por: Di, Huang, et al.
Publicado: (2022)

Identification of prognostic tumor-infiltrating immune cells in endometrial adenocarcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2021)

Prognostic factors and survival prediction for patients with metastatic lung adenocarcinoma: A population-based study
por: Wu, Bo, et al.
Publicado: (2022)

XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma: Methylation and lung adenocarcinoma
por: Zeng, Hui, et al.
Publicado: (2021)

A promising prognostic signature for lung adenocarcinoma (LUAD) patients basing on 6 hypoxia-related genes
por: Luo, Jie, et al.
Publicado: (2021)

Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer
por: Zhang, Xiaojun, et al.
Publicado: (2017)

Bioinformatics algorithm for lung adenocarcinoma based on macropinocytosis-related long noncoding RNAs as a reliable indicator for predicting survival outcomes and selecting suitable anti-tumor drugs
por: Chen, Hang, et al.
Publicado: (2022)

Molecular subtyping and prognostic risk characterization of head and neck squamous cell carcinoma based on lysosome-related genes
por: Zhang, Aichun, et al.
Publicado: (2023)

Identification of prognostic values of the transcription factor-CpG-gene triplets in lung adenocarcinoma: A narrative review
por: Lian, Duohuang, et al.
Publicado: (2022)

NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden
por: Li, Zihao, et al.
Publicado: (2023)

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
por: Chen, Jun-Rui, et al.
Publicado: (2016)

Prognostic value of metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma
por: Wang, Xiao-Yi, et al.
Publicado: (2017)

CT imaging features regarding ground-glass nodules and solid lesions reflect prognostication of synchronous multiple lung adenocarcinoma
por: Kou, Jieli, et al.
Publicado: (2022)

Identification of LGR4 as a prognostic biomarker in KRAS-mutant lung adenocarcinoma: Evidence from integrated bioinformatics analysis
por: Dodin, Yasmeen
Publicado: (2023)

The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with pancreatic ductal adenocarcinoma
por: Xu, Peng, et al.
Publicado: (2021)

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma
por: Ju, Qing, et al.
Publicado: (2021)

Kinesin superfamily member KIFC2 as an independent prognostic biomarker of colon adenocarcinoma associated with poor immune response
por: Chen, Tao, et al.
Publicado: (2023)

CircRNA6783 Inhibits Cell Proliferation and Promotes Apoptosis in Lung Adenocarcinoma
por: Mu, Yinyu, et al.
Publicado: (2022)

Relationship between marital status and survival in patients with lung adenocarcinoma: A SEER-based study
por: Wu, Ying, et al.
Publicado: (2022)

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinoma
por: Shen, Hong-Yu, et al.
Publicado: (2023)

Prognostic factors in patients with gallbladder adenocarcinoma identified using competing-risks analysis: A study of cases in the SEER database
por: Han, Didi, et al.
Publicado: (2020)

Prognosis-related autophagy genes in female lung adenocarcinoma
por: Liu, Zhongxiang, et al.
Publicado: (2022)

Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis
por: Xie, Yulian, et al.
Publicado: (2023)

Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature
por: Jiang, Shi-Yu, et al.
Publicado: (2016)

The expression and prognostic significance of Drp1 in lung cancer: A bioinformatics analysis and immunohistochemistry
por: Yu, Lingling, et al.
Publicado: (2019)

Network module function enrichment analysis of lung squamous cell carcinoma and lung adenocarcinoma
por: Li, Piaopiao, et al.
Publicado: (2022)

Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer
por: Mu, Yinyu, et al.
Publicado: (2022)

Comprehensive characterization of MUC16 mutations in lung adenocarcinoma for immunotherapies and prognosis: An observational study
por: Liu, Tingjun, et al.
Publicado: (2023)

Prognostic significance of volume-based (18)F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma
por: Wang, Dalong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hqgaoasl9fod5702u5r40kn7k2